NMSS Nancy Sicotte, M.D. Page 1 MS Learn Online Feature Presentation

First Page		Document Content
Date: 2014-01-13 20:24:20 Obstetrics Fertility Estrogens Multiple sclerosis Childbirth Menopause Pregnancy Menstrual cycle Estradiol Medicine Reproduction Human reproduction		NMSS Nancy Sicotte, M.D. Page 1 MS Learn Online Feature Presentation Add to Reading List Source URL: www.nationalmssociety.org Download Document from Source Website File Size: 110,16 KB Share Document on Facebook

	Package leaflet: Information for the user EVRA 203 micrograms/24 hours + 33.9 micrograms/24 hours transdermal patch norelgestromin/ethinyl estradiol Important things to know about combined hormonal contraceptives (CHCs): DocID: 1uZRy - View Document
	Noven Receives FDA Approval of a New Indication with a New Dose for Minivelle® (Estradiol Transdermal System) Minivelle now approved for prevention of postmenopausal osteoporosis at all doses Newmg/day Minivelle, DocID: 1ufoU - View Document
	May 21, 2018 COMDear provider of pharmaceutical services, Recall: Minivelle™ (estradiol transdermal system) At PharmPix we are committed to the health and well-being of patients. It is for this reason that DocID: 1u2U6 - View Document
	New Minivelle® (Estradiol Transdermal Systemmg/day Dose Now Available by Prescription in U.S. Pharmacies New dose approved by FDA for the prevention of postmenopausal osteoporosis only; higher doses of Minivelle DocID: 1u26h - View Document
	Package leaflet: Information for the user Mercilon® Desogestrel (150 micrograms) Ethinyl estradiol (20 micrograms) Important things to know about combined hormonal contraceptives (CHCs): DocID: 1u0f2 - View Document